Towards safety of oral anti-cancer agents, the need to educate our pharmacists

por Mekdad, Sanaa Saeed, AlSayed, Adher Dhaya
Publicado 2017

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination

por Al Sayed, Adher D., Elshenawy, Mahmoud A., Tulbah, Asma, Al-Tweigeri, Taher, Ghebeh, Hazem
Publicado 2019

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer

por Ghebeh, Hazem, Al-Sayed, Adher, Eiada, Riham, Cabangon, Leilani, Ajarim, Dahish, Suleman, Kausar, Tulbah, Asma, Al-Tweigeri, Taher
Publicado 2021

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer

por Al-Tweigeri, Taher, Elshenawy, Mahmoud, Badran, Ahmed, Omar, Ayman, Suleman, Kausar, Al Malik, Osama, Anwar, Ihab, Jastaniya, Noha, Tulbah, Asma, Al Shabanah, Mohammad, Ajarim, Dahish, Al Sayed, Adher
Publicado 2021

Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents

por Owaidah, Tarek, AlGhasham, Nahlah, AlGhamdi, Saad, AlKhafaji, Dania, ALAmro, Bandar, Zeitouni, Mohamed, Skaff, Fawaz, AlZahrani, Hazzaa, AlSayed, Adher, ElKum, Naser, Moawad, Mahmoud, Nasmi, Ahmed, Hawari, Mohannad, Maghrabi, Khalid
Publicado 2014